{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:11:53Z","timestamp":1794604313561,"version":"4.9.1"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA118100"],"award-info":[{"award-number":["P30CA118100"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018091","name":"UNM | School of Medicine, University of New Mexico","doi-asserted-by":"publisher","award":["Startup and Pilot Grants"],"award-info":[{"award-number":["Startup and Pilot Grants"]}],"id":[{"id":"10.13039\/100018091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The importance of the immune microenvironment in ovarian cancer progression, metastasis, and response to therapies has become increasingly clear, especially with the new emphasis on immunotherapies. To leverage the power of patient-derived xenograft (PDX) models within a humanized immune microenvironment, three ovarian cancer PDXs were grown in humanized NBSGW (huNBSGW) mice engrafted with human CD34+ cord blood\u2013derived hematopoietic stem cells. Analysis of cytokine levels in the ascites fluid and identification of infiltrating immune cells in the tumors demonstrated that these humanized PDX (huPDX) established an immune tumor microenvironment similar to what has been reported for patients with ovarian cancer. The lack of human myeloid cell differentiation has been a major setback for humanized mouse models, but our analysis shows that PDX engraftment increases the human myeloid population in the peripheral blood. Analysis of cytokines within the ascites fluid of huPDX revealed high levels of human M-CSF, a key myeloid differentiation factor as well as other elevated cytokines that have previously been identified in ovarian cancer patient ascites fluid including those involved in immune cell differentiation and recruitment. Human tumor-associated macrophages and tumor-infiltrating lymphocytes were detected within the tumors of humanized mice, demonstrating immune cell recruitment to tumors. Comparison of the three huPDX revealed certain differences in cytokine signatures and in the extent of immune cell recruitment. Our studies show that huNBSGW PDX models reconstitute important aspects of the ovarian cancer immune tumor microenvironment, which may recommend these models for preclinical therapeutic trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>huPDX models are ideal preclinical models for testing novel therapies. They reflect the genetic heterogeneity of the patient population, enhance human myeloid differentiation, and recruit immune cells to the tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0300","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T11:05:27Z","timestamp":1675767927000},"page":"309-324","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1226-9325","authenticated-orcid":true,"given":"Mara P.","family":"Steinkamp","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico."},{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-4008","authenticated-orcid":true,"given":"Irina","family":"Lagutina","sequence":"additional","affiliation":[{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-941X","authenticated-orcid":true,"given":"Kathryn J.","family":"Brayer","sequence":"additional","affiliation":[{"name":"3Analytical and Translational Genomics Shared Resource, Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-2290","authenticated-orcid":true,"given":"Fred","family":"Schultz","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-869X","authenticated-orcid":true,"given":"Danielle","family":"Burke","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3742-040X","authenticated-orcid":true,"given":"Vernon S.","family":"Pankratz","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico."},{"name":"5Biostatistics Shared Resource, Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-1380","authenticated-orcid":true,"given":"Sarah F.","family":"Adams","sequence":"additional","affiliation":[{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"},{"name":"6Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-9984","authenticated-orcid":true,"given":"Laurie G.","family":"Hudson","sequence":"additional","affiliation":[{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"},{"name":"7Department of Pharmaceutical Sciences, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-8909","authenticated-orcid":true,"given":"Scott A.","family":"Ness","sequence":"additional","affiliation":[{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"},{"name":"8Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0613-3157","authenticated-orcid":true,"given":"Angela","family":"Wandinger-Ness","sequence":"additional","affiliation":[{"name":"1Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico."},{"name":"2Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"2024050610061297900_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1078-0432.CCR-13-2611","article-title":"Tumorgrafts as invivo surrogates for women with ovarian cancer","volume":"20","author":"Weroha","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2024050610061297900_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fonc.2013.00295","article-title":"Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment","volume":"3","author":"Scott","year":"2013","journal-title":"Front Oncol"},{"key":"2024050610061297900_bib3","doi-asserted-by":"crossref","first-page":"28327","DOI":"10.18632\/oncotarget.5069","article-title":"Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure","volume":"6","author":"Colombo","year":"2015","journal-title":"Oncotarget"},{"key":"2024050610061297900_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/1078-0432.CCR-16-1237","article-title":"Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for preclinical evaluation of novel therapeutics","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2024050610061297900_bib5","first-page":"30","article-title":"Molecular and clinical implementations of ovarian cancer mouse avatar models","volume":"4","author":"Zayed","year":"2015","journal-title":"Chin Clin Oncol"},{"key":"2024050610061297900_bib6","doi-asserted-by":"crossref","first-page":"14495","DOI":"10.1038\/srep14495","article-title":"Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods","volume":"5","author":"Alkema","year":"2015","journal-title":"Sci Rep"},{"key":"2024050610061297900_bib7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.201700740R","article-title":"Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J"},{"key":"2024050610061297900_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage polarization in the development and progression of ovarian cancers: an overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front Oncol"},{"key":"2024050610061297900_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front Oncol"},{"key":"2024050610061297900_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2024050610061297900_bib11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2010-08-301507","article-title":"Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor\u2013, granulocyte-macrophage colony-stimulating factor\u2013, and interleukin-3\u2013expressing NOD-SCID IL2R\u03b3null humanized mice","volume":"117","author":"Billerbeck","year":"2011","journal-title":"Blood"},{"key":"2024050610061297900_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/bloodadvances.2018023887","article-title":"Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models","volume":"3","author":"Sippel","year":"2019","journal-title":"Blood Adv"},{"key":"2024050610061297900_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2024050610061297900_bib14","doi-asserted-by":"crossref","first-page":"e1320630","DOI":"10.1080\/2162402X.2017.1320630","article-title":"Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD\/SCID\/IL2Rgnull mice","volume":"6","author":"Hoogstad-van Evert","year":"2017","journal-title":"Oncoimmunology"},{"key":"2024050610061297900_bib15","doi-asserted-by":"crossref","first-page":"e1090075","DOI":"10.1080\/2162402X.2015.1090075","article-title":"Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model","volume":"5","author":"Chang","year":"2016","journal-title":"Oncoimmunology"},{"key":"2024050610061297900_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2019.10.011","article-title":"An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer","volume":"156","author":"Gitto","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2024050610061297900_bib17","doi-asserted-by":"crossref","first-page":"e001237","DOI":"10.1136\/jitc-2020-001237","article-title":"Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies","volume":"8","author":"Odunsi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2024050610061297900_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2015.06.006","article-title":"Chronic graft-versus-host-disease in CD34+-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease","volume":"62","author":"Sonntag","year":"2015","journal-title":"J Autoimmun"},{"key":"2024050610061297900_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stemcr.2014.12.005","article-title":"Nonirradiated NOD,B6.SCID Il2rgamma-\/- Kit(W41\/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells","volume":"4","author":"McIntosh","year":"2015","journal-title":"Stem Cell Reports"},{"key":"2024050610061297900_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stemcr.2016.08.005","article-title":"Improved human erythropoiesis and platelet formation in humanized NSGW41 mice","volume":"7","author":"Rahmig","year":"2016","journal-title":"Stem Cell Reports"},{"key":"2024050610061297900_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2008.03.011","article-title":"Xenografts of primary human gynecological tumors grown under the renal capsule of NOD\/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy","volume":"110","author":"Press","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2024050610061297900_bib22","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.3390\/cancers13246288","article-title":"Patient-derived xenografts of high-grade serous ovarian cancer subtype as a powerful tool in pre-clinical research","volume":"13","author":"Cybula","year":"2021","journal-title":"Cancers"},{"key":"2024050610061297900_bib23","doi-asserted-by":"crossref","first-page":"e0176675","DOI":"10.1371\/journal.pone.0176675","article-title":"Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome","volume":"12","author":"Brown","year":"2017","journal-title":"PLoS One"},{"key":"2024050610061297900_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-15-0859","article-title":"Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma","volume":"6","author":"Brayer","year":"2016","journal-title":"Cancer Discov"},{"key":"2024050610061297900_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymeth.2013.06.027","article-title":"Kraken: a set of tools for quality control and analysis of high-throughput sequence data","volume":"63","author":"Davis","year":"2013","journal-title":"Methods"},{"key":"2024050610061297900_bib26","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/gb-2014-15-3-r46","article-title":"Kraken: ultrafast metagenomic sequence classification using exact alignments","volume":"15","author":"Wood","year":"2014","journal-title":"Genome Biol"},{"key":"2024050610061297900_bib27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024050610061297900_bib28","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","article-title":"Atlas of clinically distinct cell states and ecosystems across human solid tumors","volume":"184","author":"Luca","year":"2021","journal-title":"Cell"},{"key":"2024050610061297900_bib29","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res"},{"key":"2024050610061297900_bib30","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s13277-015-3133-8","article-title":"Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients","volume":"36","author":"Wertel","year":"2015","journal-title":"Tumour Biol"},{"key":"2024050610061297900_bib31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2024050610061297900_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-016-0318-6","article-title":"Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma","volume":"9","author":"Dong","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2024050610061297900_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/gyno.1993.1085","article-title":"Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer\u2014a multivariate analysis","volume":"49","author":"Tsuruchi","year":"1993","journal-title":"Gynecol Oncol"},{"key":"2024050610061297900_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"2024050610061297900_bib35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood-2002-09-2755","article-title":"Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD\/SCID\/gammacnull mice model","volume":"102","author":"Hiramatsu","year":"2003","journal-title":"Blood"},{"key":"2024050610061297900_bib36","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41375-021-01259-5","article-title":"Enhanced differentiation of functional human T cells in NSGW41 mice with tissue-specific expression of human interleukin-7","volume":"35","author":"Coppin","year":"2021","journal-title":"Leukemia"},{"key":"2024050610061297900_bib37","first-page":"1108","article-title":"Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites","volume":"8","author":"Milliken","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2024050610061297900_bib38","first-page":"1723","article-title":"Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines","volume":"150","author":"Negus","year":"1997","journal-title":"Am J Pathol"},{"key":"2024050610061297900_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2016.172","article-title":"CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer","volume":"115","author":"Bronger","year":"2016","journal-title":"Br J Cancer"},{"key":"2024050610061297900_bib40","doi-asserted-by":"crossref","first-page":"e1424672","DOI":"10.1080\/2162402X.2018.1424672","article-title":"Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells","volume":"7","author":"Lieber","year":"2018","journal-title":"Oncoimmunology"},{"key":"2024050610061297900_bib41","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024050610061297900_bib42","first-page":"75","article-title":"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis","volume":"5","author":"Kzhyshkowska","year":"2014","journal-title":"Front Physiol"},{"key":"2024050610061297900_bib43","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.stemcr.2018.02.011","article-title":"A humanized mouse model generated using surplus neonatal tissue","volume":"10","author":"Brown","year":"2018","journal-title":"Stem Cell Reports"},{"key":"2024050610061297900_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4049\/jimmunol.2000054","article-title":"Early T cell activation metrics predict graft-versus-host disease in a humanized mouse model of hematopoietic stem cell transplantation","volume":"205","author":"Hess","year":"2020","journal-title":"J Immunol"},{"key":"2024050610061297900_bib45","doi-asserted-by":"crossref","first-page":"1867238","DOI":"10.1155\/2018\/1867238","article-title":"Malignant bowel obstruction in advanced gynecologic cancers: an updated review from a multidisciplinary perspective","volume":"2018","author":"Lee","year":"2018","journal-title":"Obstet Gynecol Int"},{"key":"2024050610061297900_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fonc.2014.00137","article-title":"Tumor-associated macrophages contribute to tumor progression in ovarian cancer","volume":"4","author":"Colvin","year":"2014","journal-title":"Front Oncol"},{"key":"2024050610061297900_bib47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/JLB.3A0218-054R","article-title":"Leukemia-derived exosomes and cytokines pave the way for entry into the brain","volume":"105","author":"Kinjyo","year":"2019","journal-title":"J Leukocyte Biol"},{"key":"2024050610061297900_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13058-018-1037-4","article-title":"Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models","volume":"20","author":"Rosato","year":"2018","journal-title":"Breast Cancer Res"},{"key":"2024050610061297900_bib49","doi-asserted-by":"crossref","first-page":"569985","DOI":"10.3389\/fonc.2020.569985","article-title":"Diverse macrophage populations contribute to the inflammatory microenvironment in premalignant lesions during localized invasion","volume":"10","author":"Ibrahim","year":"2020","journal-title":"Front Oncol"},{"key":"2024050610061297900_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fimmu.2016.00002","article-title":"Induction of monocyte chemoattractant proteins in macrophages via the production of granulocyte\/macrophage colony-stimulating factor by breast cancer cells","volume":"7","author":"Yoshimura","year":"2016","journal-title":"Front Immunol"},{"key":"2024050610061297900_bib51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fimmu.2017.01482","article-title":"Interleukin 6 present in inflammatory ascites from advanced epithelial ovarian cancer patients promotes tumor necrosis factor receptor 2-expressing regulatory T cells","volume":"8","author":"Kampan","year":"2017","journal-title":"Front Immunol"},{"key":"2024050610061297900_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol Res"},{"key":"2024050610061297900_bib53","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"Am J Cancer Res"},{"key":"2024050610061297900_bib54","first-page":"1715","article-title":"Expression of IL-10 in patients with ovarian carcinoma","volume":"26","author":"Mustea","year":"2006","journal-title":"Anticancer Res"},{"key":"2024050610061297900_bib55","first-page":"4785","article-title":"MCP-1 promotes invasion and adhesion of human ovarian cancer cells","volume":"33","author":"Furukawa","year":"2013","journal-title":"Anticancer Res"},{"key":"2024050610061297900_bib56","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/cancers13112745","article-title":"CC chemokine ligand 7 derived from cancer-stimulated macrophages promotes ovarian cancer cell invasion","volume":"13","author":"Jeong","year":"2021","journal-title":"Cancers"},{"key":"2024050610061297900_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","article-title":"Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"2024050610061297900_bib58","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.2147\/CMAR.S179189","article-title":"IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis","volume":"10","author":"Browning","year":"2018","journal-title":"Cancer Manag Res"},{"key":"2024050610061297900_bib59","doi-asserted-by":"crossref","first-page":"e000416","DOI":"10.1136\/jitc-2019-000416","article-title":"Characterization of human cancer xenografts in humanized mice","volume":"8","author":"Rios-Doria","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0300\/3268036\/crc-22-0300.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/2\/309\/3451325\/crc-22-0300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/2\/309\/3451325\/crc-22-0300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T06:07:22Z","timestamp":1714975642000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/2\/309\/716702\/Humanized-Patient-derived-Xenograft-Models-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,22]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0300","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25756556","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546651.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756568","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756556.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756574","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756562","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756553.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546672","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546660.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756562.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546657.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756571.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546660","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546654.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546663.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756568.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546654","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756565.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546353.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546672.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756565","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756553","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546669.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756574.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546666.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756559","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756559.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25756571","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546651","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546663","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546669","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546657","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.6551160","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551160.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}